Dr. Hadiyah-Nicole Green founded the Ora Lee Smith Cancer Research Foundation in memory of her aunt, Ora Lee “Auntee” Smith, whose tragic experience with cancer inspired her to develop a cancer treatment without side effects.
Ora Lee Smith raised Dr. Green from four years old, serving as her mother & legal guardian. When Auntee announced that she had cancer and would rather die than experience the harsh side effects of chemotherapy & radiation treatments, Dr. Green knew there had to be a better way. The purpose of the Ora Lee Smith Cancer Research Foundation is to support the research that Auntee inspired in hopes that one day no one else will have to opt out of treatment to avoid the side effects of today’s cancer treatment.
All donations are tax-deductible and 100% of the proceeds benefit the translation of Dr. Green’s cancer research.
Physics has made a tremendous contribution to medical science. Physicists have developed x-ray imaging, ultrasounds, MRIs, CT scans, and more. The Ora Lee Smith Cancer Research Foundation stands at the threshold of a new physics inspired medical advancement – a safe and effective treatment for cancer involving laser technology that uses nanoparticles to target and destroy cancerous cells while preserving the integrity and vitality of healthy cells.
Our treatment is notably different from other cancer treatments available today, such as chemotherapy or radiation, which can sometimes have drastic side effects permanently affecting the long-term health of patients. Our patent-pending cancer treatment does not show side effects in laboratory mice – and completely eliminates tumors in these mice over 15 days after a single 10-minute treatment. Our chief goal is to translate this groundbreaking cancer treatment from the laboratory into humans – a more than $100 million endeavor. We have the support of our team of oncologists and are ready to begin clinical trials in humans and obtain FDA approval. To accomplish our goals, we are using a nonprofit business model and tax-deductible donations to ensure treatments remain affordable after we obtain FDA approval for use in humans.
Within 24 months of reaching our fundraising goal, we plan to translate Dr. Green’s Laser- Activated Nano-Therapy (LANT) from the laboratory into humans and begin human clinical trials in head and neck cancers. Because this treatment is designed as a multi-cancer platform therapy, it has implications for a variety of tumor types, including breast, colorectal, ovarian, skin, cervical, bladder, lung, brain, anal, and prostate cancers. This advancement in treating cancer led Dr. Green to found the Ora Lee Smith Cancer Research Foundation with the mission of changing the way cancer is treated and reducing cancer-patient suffering by providing a treatment that is accessible, affordable, and, most importantly, effective.
Long term, we plan to provide cancer patients with a low cost, outpatient treatment with minimal side effects because sometimes, the traditional interventions of surgery, chemotherapy, and radiation are not enough or desired.